Description
BPC-157 & TB-500 40mg: Synergistic Tissue Repair Research
The combination of BPC-157 and TB-500 is a primary model for exploring cellular regeneration pathways. Our 40mg research kit is specifically synthesized to support studies on angiogenesis, fibroblast migration, and inflammatory signaling.
Technical Specifications of the 40mg Blend:
- BPC-157 (20mg): A pentadecapeptide researched for its interaction with vascular stability and connective tissue models.
- TB-500 (20mg): A synthetic fragment of Thymosin Beta-4, commonly studied for its role in actin regulation and cellular movement.
- Stabilized Pre-filled Pen: This medical-grade device protects the 40mg peptide chain from UV degradation and oxidation, providing a consistent baseline for long-term stability analysis.
Storage & Research Integrity:
To maintain structural integrity, store the BPC-157 & TB-500 40mg device refrigerated between 2°C and 8°C. Supplied in a fixed-volume format with an Alluvi Healthcare research information sheet. Strictly for laboratory research and development (R&D) only—not for human or veterinary consumption.
FAQ
- What is the ratio of the 40mg BPC-157 & TB-500 blend?
Each 40mg kit contains a high-purity 1:1 ratio, providing 20mg of BPC-157 and 20mg of TB-500 for synergistic R&D. - Is the BPC-157 & TB-500 40mg pen lab-tested?
Yes, our formulation is verified at 99%+ purity via HPLC testing to ensure professional research accuracy. - How is the research kit shipped in the UK?
All kits are dispatched in specialized insulated packaging with cold packs to preserve peptide potency during tracked 2-day delivery.
Reviews
There are no reviews yet.